Search Results - "Uhrich, Margaret"

The Goal Inventory: An Innovative Digital Resource to Help Patients Identify and Evaluate Their Goals by Cripe, Larry D., Cottingham, Ann H., Monahan, Patrick O., Stump, Timothy E., Shuler, Miranda G., Comer, Robert S., Martin, Caroline E., Uhrich, Margaret M., Gilmore, Alexis

Get full text

Oncology Nurses’ Narratives About Ethical Dilemmas and Prognosis-Related Communication in Advanced Cancer Patients by McLennon, Susan M, Uhrich, Margaret, Lasiter, Sue, Chamness, Amy R, Helft, Paul R

“…BACKGROUND:Oncology nurses routinely encounter ethical dilemmas when caring for advanced cancer patients, particularly concerning prognosis-related…”
Get full text

Oncology nurses' attitudes toward prognosis-related communication: a pilot mailed survey of oncology nursing society members by Helft, Paul R, Chamness, Amy, Terry, Colin, Uhrich, Margaret

“…To assess oncology nurses' attitudes toward prognosis-related communication and experiences of the quality of such communication among physicians…”
Get full text

Suramin: a novel growth factor antagonist with activity in hormone-refractory metastatic prostate cancer by Myers, C, Cooper, M, Stein, C, LaRocca, R, Walther, M M, Weiss, G, Choyke, P, Dawson, N, Steinberg, S, Uhrich, M M

“…Suramin is known to inhibit the growth of malignant prostate carcinoma cells in vitro. This led us to evaluate the effectiveness of suramin in the treatment of…”
Get more information

Serotonergic blockade in the treatment of the cancer anorexia‐cachexia syndrome by Edelman, Martin J., Gandara, David R., Meyers, Frederick J., Ishii, Rie, O'Mahony, Michael, Uhrich, Margaret, Lauder, Ignacio, Houston, Joan, Gietzen, Dorothy W.

“…BACKGROUND Imbalanced amino acid diets in animals rapidly produce anorexia and weight loss. Blockade of type 3 serotonergic receptors (5HT3) can ameliorate…”
Get full text

Phase I trial of edatrexate plus carboplatin in advanced solid tumors : amelioration of dose-limiting mucositis by ice chip cryotherapy by EDELMAN, M. J, GANDARA, D. R, PEREZ, E. A, LAU, D, LAUDER, I, TURRELL, C, UHRICH, M, MEYERS, F

“…Edatrexate (10-Edam) is a methotrexate analog with improved intracellular transport, polyglutamation, and antitumor activity compared to the parent compound…”
Get full text

High-dose toremifene as a cisplatin modulator in metastatic non-small cell lung cancer : targeted plasma levels are achievable clinically by LARA, P. N, GANDARA, D. R, MUGGIA, F, PEREZ, E. A, DEGREGORIO, M, WURZ, G. T, LAU, D, UHRICH, M, TURRELL, C, RASCHKO, J, EDELMAN, M. J, SYNOLD, T, DOROSHOW, J

“…The triphenylethylenes tamoxifen and toremifene have been reported to enhance the cytotoxicity of cisplatin by inhibition of protein kinase C (PKC) signal…”
Get full text

A pilot study of suramin in the treatment of metastatic renal cell carcinoma by La Rocca, R V, Stein, C A, Danesi, R, Cooper, M R, Uhrich, M, Myers, C E

“…Suramin sodium is an aromatic polysulfonated compound that was originally introduced as an antiparasitic agent in the 1920s. Recently, in view of its ability…”
Get more information

Use of suramin in treatment of prostatic carcinoma refractory to conventional hormonal manipulation by LaRocca, R V, Cooper, M R, Uhrich, M, Danesi, R, Walther, M M, Linehan, W M, Myers, C E

“…Suramin and related compounds, in view of their growth factor and enzyme binding properties, represent in many respects a novel approach to the treatment of…”
Get more information